CareDx, Inc
CDNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.1% | -12.9% | 8.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.2% | 63.6% | 65.1% | 67.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10.2% | -30.3% | -19% | -6% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 15.7% | -67.9% | -23.8% | -10.3% |
| EPS Diluted | 0.93 | -3.54 | -1.44 | -0.59 |
| % Growth | 126.3% | -145.8% | -144.1% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |